Diversified Healthcare Trust (NASDAQ:DHC) Releases FY 2026 Earnings Guidance

Key Points

• Diversified Healthcare Trust issued FY 2026 EPS guidance of $0.46–$0.52, below the consensus estimate of $0.60.
• The REIT’s latest quarter fell short of expectations, reporting a $0.21 loss per share versus the projected $0.15 loss, while revenue also missed estimates.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $9.83, while DHC declared a quarterly dividend of $0.01 per share, equal to a 0.5% annualized yield.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.460-0.520 for the period, compared to the consensus earnings per share estimate of 0.600.

Wall Street Analyst Weigh In

DHC has been the subject of several analyst reports. Weiss Ratings restated a "sell (d-)" rating on shares of Diversified Healthcare Trust in a research report on Thursday, October 15th. Wall Street Zen upgraded shares of Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $9.83.

Diversified Healthcare Trust Price Performance

Shares of DHC stock opened at $7.74 on Tuesday. The company has a quick ratio of 4.67, a current ratio of 4.66 and a debt-to-equity ratio of 1.52. Diversified Healthcare Trust has a twelve month low of $3.92 and a twelve month high of $9.66. The company has a market cap of $1.87 billion, a P/E ratio of -6.97 and a beta of 2.29. The business has a fifty day simple moving average of $7.76 and a 200 day simple moving average of $7.76.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last released its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.06). Diversified Healthcare Trust had a negative net margin of 17.73% and a negative return on equity of 16.22%. The business had revenue of $367.67 million during the quarter, compared to analyst estimates of $370.87 million. On average, sell-side analysts forecast that Diversified Healthcare Trust will post 0.60 EPS for the current fiscal year.

Diversified Healthcare Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 12th. Stockholders of record on Monday, October 19th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, October 19th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.5%. Diversified Healthcare Trust's dividend payout ratio is -3.60%.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust NASDAQ: DHC is a real estate investment trust that owns and manages healthcare-related properties in the United States. Its portfolio includes medical office buildings, life science and research facilities, senior living communities, and wellness-oriented properties.

The trust leases its properties to healthcare providers, research organizations, senior living operators, and other related businesses. Its medical office and life science properties support outpatient care, medical research, and healthcare innovation, while its senior living portfolio serves older adults through independent living, assisted living, and related care services.

DHC was formerly known as Senior Housing Properties Trust and adopted its current name in 2020 to reflect its broader healthcare real estate strategy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.